# Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants

> **NCT03320603** · NA · COMPLETED · sponsor: **Octapharma** · enrollment: 397 (actual)

## Conditions studied

- Emergency Care for Severe Bleeding While on Anticoagulants

## Interventions

- **OTHER:** Expert eCRF
- **OTHER:** Prothrombin Complex Concentrate

## Key facts

- **NCT ID:** NCT03320603
- **Lead sponsor:** Octapharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-13
- **Primary completion:** 2020-12-20
- **Final completion:** 2020-12-20
- **Target enrollment:** 397 (ACTUAL)
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03320603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03320603, "Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03320603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*